Masimo Corporation (NASDAQ:MASI) Shares Acquired by Sigma Planning Corp

Sigma Planning Corp increased its stake in shares of Masimo Corporation (NASDAQ:MASI - Free Report) by 89.2% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 6,365 shares of the medical equipment provider's stock after purchasing an additional 3,000 shares during the period. Sigma Planning Corp's holdings in Masimo were worth $1,060,000 as of its most recent SEC filing.

Several other institutional investors have also recently modified their holdings of the stock. Jones Financial Companies Lllp purchased a new stake in Masimo in the 4th quarter worth approximately $27,000. Farther Finance Advisors LLC grew its stake in Masimo by 128.9% in the 1st quarter. Farther Finance Advisors LLC now owns 206 shares of the medical equipment provider's stock worth $35,000 after acquiring an additional 116 shares during the period. EverSource Wealth Advisors LLC grew its stake in Masimo by 40.0% in the 4th quarter. EverSource Wealth Advisors LLC now owns 224 shares of the medical equipment provider's stock worth $37,000 after acquiring an additional 64 shares during the period. NBC Securities Inc. purchased a new stake in Masimo in the 1st quarter worth approximately $61,000. Finally, UMB Bank n.a. grew its stake in Masimo by 134.0% in the 1st quarter. UMB Bank n.a. now owns 447 shares of the medical equipment provider's stock worth $74,000 after acquiring an additional 256 shares during the period. 85.96% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling

In other Masimo news, COO Bilal Muhsin sold 10,000 shares of the business's stock in a transaction on Monday, May 12th. The shares were sold at an average price of $163.28, for a total value of $1,632,800.00. Following the transaction, the chief operating officer owned 24,172 shares in the company, valued at $3,946,804.16. The trade was a 29.26% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. 9.70% of the stock is owned by corporate insiders.

Masimo Stock Down 0.7%

Masimo stock traded down $1.10 during trading on Thursday, reaching $158.35. 491,420 shares of the company's stock were exchanged, compared to its average volume of 633,988. The company's 50-day moving average is $162.14 and its two-hundred day moving average is $166.04. The company has a debt-to-equity ratio of 0.67, a quick ratio of 1.62 and a current ratio of 2.17. Masimo Corporation has a 52-week low of $101.61 and a 52-week high of $194.88. The firm has a market cap of $8.59 billion, a price-to-earnings ratio of -17.27 and a beta of 1.19.

Masimo (NASDAQ:MASI - Get Free Report) last announced its quarterly earnings results on Tuesday, May 6th. The medical equipment provider reported $1.36 earnings per share for the quarter, topping analysts' consensus estimates of $1.24 by $0.12. Masimo had a negative net margin of 25.06% and a positive return on equity of 22.56%. The firm had revenue of $372.00 million during the quarter, compared to analysts' expectations of $367.79 million. During the same period in the prior year, the company earned $0.77 EPS. The firm's revenue was down 24.5% on a year-over-year basis. On average, analysts predict that Masimo Corporation will post 4.1 earnings per share for the current year.

Wall Street Analyst Weigh In

Several research firms have commented on MASI. BTIG Research reaffirmed a "buy" rating on shares of Masimo in a research note on Monday. Piper Sandler reissued an "overweight" rating and set a $200.00 price objective (down from $215.00) on shares of Masimo in a research note on Wednesday, May 7th. Needham & Company LLC reissued a "hold" rating on shares of Masimo in a research note on Thursday, April 10th. Wells Fargo & Company lowered their price objective on shares of Masimo from $205.00 to $190.00 and set an "overweight" rating for the company in a research note on Wednesday, May 7th. Finally, Wall Street Zen cut shares of Masimo from a "buy" rating to a "hold" rating in a research note on Friday, May 30th. Two equities research analysts have rated the stock with a hold rating and five have issued a buy rating to the company's stock. According to data from MarketBeat.com, Masimo presently has an average rating of "Moderate Buy" and an average price target of $191.60.

Masimo Company Profile

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.